Soft Tissue Sarcomas: Current Management and Future Directions

Surgical Clinics of North America

Volumn 89, Issue 1, 2009, Pages 235-247

  Kenney, Robert J ^a   Cheney, Richard ^b   Stull, Margaret A ^c   Kraybill, William ^a,c  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c ST LUKE S HOSPITAL   (United States)

Author keywords

Cancer; Chemotherapy; Radiation; Soft tissue sarcoma; Tissue sampling

Indexed keywords

DACARBAZINE; DOXORUBICIN; IFOSFAMIDE;

CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER THERAPY; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; ECHOGRAPHY; HUMAN; LIMB; METASTASIS; MOLECULAR GENETICS; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; RETROPERITONEAL SARCOMA; REVIEW; SAMPLING; SOFT TISSUE SARCOMA; TRUNK; TUMOR BIOPSY;

DIAGNOSTIC IMAGING; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROPERITONEAL NEOPLASMS; SARCOMA; TREATMENT OUTCOME;

EID: 58749085250     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suc.2008.09.020     Document Type: Review

References (61)

1. Pisters P., Bramwell V., Rubin B., et al. Sarcomas of soft tissue. In: Abeloff M., Armitage J., Niederhuber J., et al. (Eds). Clinical Oncology. 3rd edition (2004), Elsevier Inc, Philadelphia 2573-2626
2. Fletcher C., Unni K.K., and Mertens F. WHO Classification of Soft Tissue Tumors. In: Fletcher C., Unni K.K., and Mertens F. (Eds). Pathology and Genetics: Tumors of Soft Tissue and Bone. World Health Organization Classification of Tumors (2002), International Agency for Research on Cancer Press 9-12
3. Skubitz K., and D'Adamo D. Sarcoma. Mayo Clin Proc 82 11 (2007) 1409-1432
4. Toro J., Travis L., Wu H.J., et al. Incidence patterns of soft tissue sarcomas, regardless of primary site, in the Surveillance, Epidemiology, and End Results Program, 1978-2001: an analysis of 26,758 cases. Int J Cancer 119 (2006) 2922-2930
5. Hawkins M.M., Draper G.J., and Kingston J.E. Incidence of second primary tumours among childhood cancer survivors. Br J Cancer 56 (1987) 339-347
6. Gonin-Laurent N., Hadj-Hamou N.S., Vogt N., et al. RB1 and TP53 pathways in radiation-induced Sarcomas. Oncogene 26 41 (2007) 6106-6112
7. Stewart N.J., Pritchard D.J., Nascimento A.G., et al. Lymphangiosarcoma following mastectomy. Clin Orthop Relat Res 320 (1995) 135-141
8. Schiffman S., and Berger A. Stewart-Treves syndrome. J Am Coll Surg 204 2 (2007) 328
9. Memar O.M., Rady P.L., and Tyring S.K. Human herpesvirus-8: detection of novel herpesvirus-like DNA sequences in Kaposi's sarcoma and other lesions. J Mol Med 73 (1995) 603-609
10. Fernebro J., Bladstrom A., Rydholm A., et al. Increased risk of malignancies in a population-based Study of 818 soft-tissue sarcoma patients. Br J Cancer 95 (2006) 986-990
11. Coindre J.M. Grading of soft tissue sarcomas: review and update. Arch Pathol Lab Med 130 (2006) 1448-1453
12. Guillou L., Coindre J.M., Bonichon F., et al. Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group Grading Systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol 15 (1997) 350-362
13. Mariani L., Miceli R., Kattan M., et al. Validation and adaptation of a nomogram for predicting the survival of patients with extremity soft tissue sarcoma using a three-grade system. Cancer 103 2 (2005) 402-408
14. Kattan M.W., Leung D.H., and Brennan M.F. Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol 20 (2002) 791-796
15. Eilber F., and Kattan M.W. Sarcoma nomogram: validation and a model to evaluate impact of therapy. J Am Coll Surg 205 4S (2007) S90-S95
16. Noria S., Davis A., Kandel R., et al. Residual disease following unplanned excision of a soft-tissue sarcoma of an extremity. J Bone Joint Surg Am 78 5 (1996) 650-655
17. Gutierrez J.C., Perez E.A., Moffat F.L., et al. Should soft tissue sarcomas be treated at high-volume centers? An analysis of 4205 Patients. Ann Surg 245 6 (2007) 952-958
18. Sarcoma Progress Review Group. A roadmap for sarcoma research (2004), US Department of Health and Human Services. http://plan2005.cancer.gov/disease.html Accessed June 2008
19. Ilaslan H., and Sundaram M. Advances in musculoskeletal tumor imaging. Orthop Clin North Am 37 3 (2006) 375-391
20. 18F-FDG PET for the diagnosis and grading of soft-tissue sarcoma: a meta-analysis. J Nucl Med 44 (2003) 717-724
21. Bredella M.A., Caputo G.R., and Steinbach L.S. Value of FDG positron emission tomography in conjunction with MR imaging for evaluating therapy response in patients with musculoskeletal sarcomas. Am J Roentgenol 179 (2002) 1145-1150
22. Mankin H.J., Lange T.A., and Spanier S.S. The hazards of biopsy in patients with malignant primary bone and soft-tissue tumors. J Bone Joint Surg Am 64 (1982) 1121-1127
23. Mankin H.J., Mankin C.J., and Simon M. The hazards of the biopsy, revisited. For the Members of the Musculoskeletal Tumor Society. J Bone Joint Surg Am 78 5 (1996) 656-663
24. Skrzynski M.C., Biermann J.S., Montag A., et al. Diagnostic accuracy and charge-savings of outpatient core needle biopsy compared with open biopsy of musculoskeletal tumors. J Bone Joint Surg Am 78 5 (1996) 644-649
25. Altuntas A., Flavin J., and Smith P. Accuracy of computed tomography core needle biopsy of musculoskeletal tumours. ANZ J Surg. 75 (2005) 187-191
26. Soudack M, Nachtigal A, Vladovski E, et al. Sonographically guided percutaneous needle biopsy of soft tissue masses with histopathologic correlation. J Ultrasound Med 2006;25:1271-7.
27. Kenney R., Cheney R., and Kraybill W. Core biopsy for diagnosis and tissue procurement. J Surg Oncol 97 5 (2008) 374-375
28. Rosenberg S.A., Tepper J., Glatstein E., et al. The treatment of soft tissue sarcoma of the extremities: prospective randomized evaluation of 1) limb-sparing surgery plus radiation therapy compared with amputation and 2) the role of adjuvant chemotherapy. Ann Surg 196 (1982) 305-315
29. Pisters P.W., Leung D.H., Woodruff J., et al. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol 14 (1996) 1679-1689
30. McKay A., Motamedi M., Temple W., et al. Vascular reconstruction with the superficial femoral vein following major oncologic resection. J Surg Oncol 96 (2007) 151-159
31. Schwarzbach M.H., Hormann Y., Hinz U., et al. Results of limb-sparing surgery with vascular replacement for soft tissue sarcoma in the lower extremity. J Vasc Surg 42 1 (2005) 88-97
32. Shafir M., Holland J., Cohen B., et al. Radical retroperitoneal tumor surgery with resection of the psoas major muscle. Cancer 56 4 (1985) 929-933
33. Brooks A., Gold J., Graham D., et al. Resection of the sciatic, peroneal, or tibial nerves: assessment of functional status. Ann Surg Oncol 9 1 (2002) 41-47
34. Stojadinovic A., Jaques D., Denis H., et al. Amputation for recurrent soft tissue sarcoma of the extremity: indications and outcome. Ann Surg Oncol 8 6 (2001) 509-518
35. Ghert M., Abudu A., Driver N., et al. The indications for and the prognostic significance of amputation as the primary surgical procedure for localized soft tissue sarcoma of the extremity. Ann Surg Oncol 12 1 (2005) 10-17
36. Schlag P., and Tunn P. Isolated limb perfusion in advanced soft tissue sarcomas. In: Schlag P., and Tunn P. (Eds). Regional Cancer Therapy (2007), Humana Press Inc., Totowa 407-417
37. Thijssens K.M., van Ginkel R.J., Pras E., et al. Isolated limb perfusion with tumor necrosis factor alpha and melphalan for locally advanced soft tissue sarcoma: the value of adjuvant radiotherapy. Ann Surg Oncol 13 4 (2006) 518-524
38. Hoven-Gondrie M., Thijssens K.M., Van den Dungen J.J., et al. Long-term locoregional vascular morbidity after isolated limb perfusion and external-beam radiotherapy in soft tissue sarcoma of the extremity. Ann Surg Oncol 12 5 (2005) 406-411
39. Fiore M., Casali P., Rosalba M., et al. Prognostic effect of re-excision in adult soft tissue sarcoma of the extremity. Ann Surg Oncol 13 1 (2006) 110-117
40. Pisters P.W., Pollock R.E., Lewis V.O., et al. Long-term results of prospective trial of surgery alone with selective use of radiation for patients with T1 extremity and trunk soft tissue sarcomas. Ann Surg 246 4 (2007) 675-681
41. Tseng J.F., Ballo M.T., Langstein H.N., et al. The effect of preoperative radiotherapy and reconstructive surgery on wound complications after resection of extremity soft-tissue sarcomas. Ann Surg Oncol 13 9 (2006) 1209-1215
42. O'Sullivan B., Davis A., Turcotte R., et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet 359 (2002) 2235-2241
43. Pisters P.W., Harrison L.B., Woodruff J.M., et al. A prospective randomized trial of adjuvant brachytherapy in the management of low-grade soft tissue sarcomas of the extremity and superficial trunk. J Clin Oncol 12 (1994) 1150-1155
44. Pisters P.W., Harrison L.B., Leung D.H., et al. Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol 14 3 (1996) 859-868
45. Sarcoma Meta-analysis Collaboration. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Lancet 350 (1997) 1647-1654
46. Bramwell V. Adjuvant chemotherapy for adult soft tissue sarcoma: is there a standard of care?. J Clin Oncol 19 5 (2001) 1235-1237
47. Spiro I., Gebhardt M., Jennings L., et al. Prognostic factors for local control of sarcomas of the soft tissues managed by radiation and surgery. Semin Oncol 24 (1997) 540-546
48. Kraybill W., Harris J., Spiro I., et al. Phase II study of neoadjuvant chemotherapy and radiation therapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514. J Clin Oncol 24 4 (2006) 619-625
49. Pawlik T., Pisters P., Mikula L., et al. Long-term results of two prospective trials of preoperative external beam radiotherapy for localized intermediate- or high-grade retroperitoneal soft tissue sarcoma. Ann Surg Oncol 13 4 (2006) 508-517
50. Woodall C.E., and Scoggins C.R. Retroperitoneal and visceral sarcomas: issues for the general surgeon. Am Surg 73 (2007) 631-635
51. Demetri GD, Heslin MJ, Pfeifer JD, et al. Practice Guidelines in oncology: soft tissue sarcoma. Available at: www.NCCN.org. Accessed November 9, 2008.
52. Whooley B.P., Mooney M.M., Gibbs J.F., et al. Effective follow-up strategies in soft tissue sarcoma. Semin Surg Oncol 17 1 (1999) 83-87
53. Gadd M.A., Casper E.S., Woodruff J.M., et al. Development and treatment of pulmonary metastases in adult patients with extremity soft tissue sarcoma. Ann Surg 218 6 (1993) 705-712
54. Jablons D., Steinberg S., Roth J., et al. Metastectomy for soft tissue sarcoma. Further evidence for efficacy and prognostic indicators. J Thorac Cardiovasc Surg 97 5 (1989) 695-705
55. van Geel A.N., Pastorino U., Jauch K.W., et al. Surgical treatment of lung metastases: the European Organization for Research and Treatment of cancer-soft tissue and Bone Sarcoma Group Study of 255 patients. Cancer 77 4 (1996) 675-682
56. Billingsley K., Burt M., Jara E., et al. Pulmonary metastases from soft tissue sarcoma: analysis of patterns of disease and postmetastasis survival. Ann Surg 229 5 (1999) 602-610
57. Weiser M., Downey R., Leung D., et al. Repeat resection of pulmonary metastases in patients with soft-tissue sarcoma. J Am Coll Surg 191 2 (2000) 184-190
58. Bramwell V., Anderson D., Charette M., et al. Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft tissue sarcoma. Cochrane Database Syst Rev 4 (2001) CD003293
59. Maki R., Wathen J., Shreyaskumar R., et al. Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002. J Clin Oncol 25 19 (2007) 2755-2763
60. Borden E., Baker L., Bell R., et al. Soft tissue sarcomas of adults: state of the translational science. Clin Cancer Res 9 (2003) 1941-1956
61. Nielsen T., West R., Linn S., et al. Molecular characterisation of soft tissue tumours: a gene expression study. Lancet 359 (2002) 1301-1307